Editorially Independent Content, Supported with Advertising from Allergan XEN, Glaukos iDose & Nova Eye.
John P. Berdahl, MD; Natalia Morales, MD; and Justin Schweitzer, OD, FAAO
Show Description +
John Berdahl, MD, invites Natalia Morales, MD, and Justin Schweitzer, OD, FAAO, to review a case of an 81-year-old patient with moderate glaucoma who had struggled with medications in the past. The patient also presented with a visual field defect and lattice corneal dystrophy. Dr. Morales reviews treatment options for this case and the panel describes the preferred approach of iStent infinite and iDose TR implantation (Glaukos).
Posted: 4/07/2026
John P. Berdahl, MD; Natalia Morales, MD; and Justin Schweitzer, OD, FAAO
John Berdahl, MD, invites Natalia Morales, MD, and Justin Schweitzer, OD, FAAO, to review a case of an 81-year-old patient with moderate glaucoma who had struggled with medications in the past. The patient also presented with a visual field defect and lattice corneal dystrophy. Dr. Morales reviews treatment options for this case and the panel describes the preferred approach of iStent infinite and iDose TR implantation (Glaukos).
Posted: 4/07/2026
Please log in to leave a comment.